U.S. endocrine-focused pharmaceutical development and commercialization firm Crinetics Pharmaceuticals has confirmed an ongoing investigation into a cybersecurity incident claimed by the LockBit ransomware operation.
Source: SC Magazine
UnitedHealth, insurers called to act following Change Healthcare hack
- Securing the future of IoT: Why attack surface management is key
- No more 12345: devices with weak passwords to be banned in UK
- 20 Best Linux Password Managers in 2024
- Reliable Web App Pattern: Now Optimizes Azure Migration with Enhanced Infrastructure and Security
- Okta Warns of Unprecedented Surge in Proxy-Driven Credential Stuffing Attacks